Literature DB >> 15531480

Intrafamilial variability of the deafness and goiter phenotype in Pendred syndrome caused by a T416P mutation in the SLC26A4 gene.

Ulrike Napiontek1, Guntram Borck, Wiebke Müller-Forell, Nicole Pfarr, Andrea Bohnert, Annerose Keilmann, Joachim Pohlenz.   

Abstract

Pendred syndrome (PS) is the most common cause of syndromic deafness, accounting for more than 5% of all autosomal-recessive hearing loss cases. It is characterized by bilateral sensorineural hearing loss and by goiter with or without hypothyroidism. Mutations in the SLC26A4 gene cause both classical PS and deafness associated with an enlarged vestibular aqueduct without goiter. To investigate a possible genotype-phenotype correlation in PS, we performed a detailed clinical and genetic study in three adult German sibs with typical PS caused by a common homozygous SLC26A4 mutation, T416P. An audiological long-term follow-up of 23 yr showed that the mutation T416P is associated with a distinct type of hearing loss in each of the three sibs: moderate-to-profound progressive deafness, profound nonprogressive deafness, and a milder but more rapidly progressing form. We show that these phenotypic differences are not caused by either different degrees of inner ear malformations or sequence variations in the GJB2/connexin 26 gene. Because the thyroid phenotype was also highly variable within the family, with thyroid sizes ranging from normal to large goiters requiring thyroidectomy, this study leads to the conclusion that other environmental and/or genetic factors have an impact on the PS phenotype.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15531480     DOI: 10.1210/jc.2004-1013

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  Genetic variation in thyroid folliculogenesis influences susceptibility to hypothyroidism-induced hearing impairment.

Authors:  Amanda H Mortensen; Qing Fang; Michelle T Fleming; Thomas J Jones; Alexandre Z Daly; Kenneth R Johnson; Sally A Camper
Journal:  Mamm Genome       Date:  2019-02-18       Impact factor: 2.957

Review 2.  Integration of human and mouse genetics reveals pendrin function in hearing and deafness.

Authors:  Amiel A Dror; Zippora Brownstein; Karen B Avraham
Journal:  Cell Physiol Biochem       Date:  2011-11-18

3.  Absence of primary hypothyroidism and goiter in Slc26a4 (-/-) mice fed on a low iodine diet.

Authors:  D Calebiro; P Porazzi; M Bonomi; S Lisi; A Grindati; D De Nittis; L Fugazzola; M Marinò; G Bottà; L Persani
Journal:  J Endocrinol Invest       Date:  2010-09-09       Impact factor: 4.256

4.  Pendred syndrome among patients with congenital hypothyroidism detected by neonatal screening: identification of two novel PDS/SLC26A4 mutations.

Authors:  Karolina Banghova; Eva Al Taji; Ondrej Cinek; Dana Novotna; Radka Pourova; Jirina Zapletalova; Olga Hnikova; Jan Lebl
Journal:  Eur J Pediatr       Date:  2007-09-18       Impact factor: 3.183

5.  Functional assessment of allelic variants in the SLC26A4 gene involved in Pendred syndrome and nonsyndromic EVA.

Authors:  Alejandra Pera; Silvia Dossena; Simona Rodighiero; Marta Gandía; Guido Bottà; Giuliano Meyer; Felipe Moreno; Charity Nofziger; Concepción Hernández-Chico; Markus Paulmichl
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-18       Impact factor: 11.205

6.  Pathogenic substitution of IVS15 + 5G > A in SLC26A4 in patients of Okinawa Islands with enlarged vestibular aqueduct syndrome or Pendred syndrome.

Authors:  Akira Ganaha; Tadashi Kaname; Kumiko Yanagi; Kenji Naritomi; Tetsuya Tono; Shin-ichi Usami; Mikio Suzuki
Journal:  BMC Med Genet       Date:  2013-05-24       Impact factor: 2.103

7.  Genomic analysis of a heterogeneous Mendelian phenotype: multiple novel alleles for inherited hearing loss in the Palestinian population.

Authors:  Tom Walsh; Amal Abu Rayan; Judeh Abu Sa'ed; Hashem Shahin; Jeanne Shepshelovich; Ming K Lee; Koret Hirschberg; Mustafa Tekin; Wa'el Salhab; Karen B Avraham; Mary-Claire King; Moien Kanaan
Journal:  Hum Genomics       Date:  2006-01       Impact factor: 4.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.